---
figid: PMC4251421__medrep-06-116-g002
figtitle: Simplified diagram of the mammalian target of rapamycin (mTOR) signaling
  pathway and its relationship with autophagy and apoptosis
organisms:
- NA
pmcid: PMC4251421
filename: medrep-06-116-g002.jpg
figlink: /pmc/articles/PMC4251421/figure/fig-002/
number: F2
caption: 'Tuberous sclerosis complex (TSC)1/2 integrates multiple signals to control
  cell size and proliferation. TSC1/2 regulates mammalian target of rapamycin (mTOR)
  complex 1 mTORC1 negatively through its actions on Rheb. Activation of mTORC1 leads
  to protein translation, cell growth and proliferation. mTORC1 is a major regulator
  of autophagy. Blockade of mTORC1 by sirolimus augments autophagy, leading to increased
  cell survival. This effect can be inhibited by hydroxychloroquine. mTOR complex
  2 (mTORC2) regulates the actin cytoskeleton through Rho GTPases, which affect cell
  migration, morphogenesis and apoptosis. Simvastatin reduces Rheb and Rho activities
  and promotes apoptosis. Combined therapy with sirolimus, hydroxychloroquine or simvastatin
  may act synergically to inhibit lymphangioleiomyomatosis (LAM) cell growth and promote
  apoptosis.Abbreviations: Akt, protein kinase B; mTOR, mammalian target of rapamycin;
  mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; Rac, small GTPase binding protein
  of the Rho family; Rheb, Ras homolog enriched in brain; S6K1, S6 kinase 1; 4E-BP1,
  factor 4E binding protein 1; TSC, tuberous sclerosis complex.'
papertitle: Management of lymphangioleiomyomatosis.
reftext: Angelo M. Taveira-DaSilva, et al. F1000Prime Rep. 2014;6:116.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.938184
figid_alias: PMC4251421__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC4251421__F2
ndex: 63eb2e32-deb7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4251421__medrep-06-116-g002.html
  '@type': Dataset
  description: 'Tuberous sclerosis complex (TSC)1/2 integrates multiple signals to
    control cell size and proliferation. TSC1/2 regulates mammalian target of rapamycin
    (mTOR) complex 1 mTORC1 negatively through its actions on Rheb. Activation of
    mTORC1 leads to protein translation, cell growth and proliferation. mTORC1 is
    a major regulator of autophagy. Blockade of mTORC1 by sirolimus augments autophagy,
    leading to increased cell survival. This effect can be inhibited by hydroxychloroquine.
    mTOR complex 2 (mTORC2) regulates the actin cytoskeleton through Rho GTPases,
    which affect cell migration, morphogenesis and apoptosis. Simvastatin reduces
    Rheb and Rho activities and promotes apoptosis. Combined therapy with sirolimus,
    hydroxychloroquine or simvastatin may act synergically to inhibit lymphangioleiomyomatosis
    (LAM) cell growth and promote apoptosis.Abbreviations: Akt, protein kinase B;
    mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; mTORC2, mTOR complex
    2; Rac, small GTPase binding protein of the Rho family; Rheb, Ras homolog enriched
    in brain; S6K1, S6 kinase 1; 4E-BP1, factor 4E binding protein 1; TSC, tuberous
    sclerosis complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSC1
  - CCL26
  - TSC2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - RHEB
  - RHEBP1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RPTOR
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - EIF4EBP1
  - RPS6KB1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Tsc1
  - gig
  - Akt
  - Rheb
  - Rac1
  - Rac2
  - Mtl
  - Crtc
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Thor
  - S6k
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Chloroquine
  - Simvastatin
  - Rapamycin
---
